MINAPHARM Pharmaceuticals Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,558	4,114	1,796	2,408	1,822	1,303
Market Cap Growth	189.24%	129.01%	-25.41%	32.19%	39.82%	32.02%
Enterprise Value	8,776	5,812	4,355	4,087	2,625	1,448
Last Close Price	641.55	349.20	160.66	213.62	143.60	100.70
PE Ratio	1142.44	621.84	14.01	-	3.09	2.91
PS Ratio	1.17	0.64	0.32	0.62	0.50	0.43
PB Ratio	1.19	0.65	0.42	0.69	0.60	0.67
P/TBV Ratio	1.37	0.75	0.50	0.80	0.70	0.81
P/OCF Ratio	16.26	8.85	8.11	23.53	3.24	6.29
EV/Sales Ratio	1.36	0.90	0.78	1.05	0.73	0.48
EV/EBITDA Ratio	6.27	4.31	3.72	7.63	2.42	1.73
EV/EBIT Ratio	8.62	5.71	4.66	10.91	2.72	1.92
Debt / Equity Ratio	0.71	0.71	1.30	1.08	0.80	0.64
Debt / EBITDA Ratio	3.25	3.25	4.58	6.71	2.22	1.49
Net Debt / Equity Ratio	0.18	0.18	0.63	0.54	0.24	0.14
Net Debt / EBITDA Ratio	0.82	0.82	2.29	3.52	0.68	0.32
Net Debt / FCF Ratio	-3.44	-3.44	-3.85	-1.46	-1.24	-1.47
Asset Turnover	0.51	0.51	0.54	0.50	0.66	0.79
Inventory Turnover	3.03	3.03	3.21	2.79	2.82	2.90
Quick Ratio	0.82	0.82	0.75	0.70	0.87	0.92
Current Ratio	1.30	1.30	1.21	1.15	1.46	1.61
Return on Equity (ROE)	0.89%	0.89%	4.13%	0.68%	25.32%	26.86%
Return on Assets (ROA)	5.06%	5.06%	5.63%	3.02%	11.05%	12.42%
Return on Invested Capital (ROIC)	3.00%	3.11%	8.69%	5.52%	23.09%	28.67%
Return on Capital Employed (ROCE)	12.20%	12.20%	12.80%	7.20%	22.40%	28.80%
Earnings Yield	0.09%	0.98%	8.74%	-1.33%	33.63%	35.79%
FCF Yield	-4.27%	-7.85%	-38.82%	-53.66%	-32.84%	-13.86%
Dividend Yield	0.38%	-	1.56%	0.77%	1.95%	2.90%
Payout Ratio	149.97%	149.97%	25.57%	-	9.43%	10.68%
Buyback Yield / Dilution	-	-	-	3.57%	6.67%	-
Total Shareholder Return	0.38%	-	1.56%	4.34%	8.62%	2.90%